Share This Article:

Endothelin-2 Differential Expression in Normal and Early-Stages of Colon Cancer Development

Abstract Full-Text HTML Download Download as PDF (Size:4349KB) PP. 26-33
DOI: 10.4236/jct.2013.46A2004    3,728 Downloads   5,120 Views   Citations

ABSTRACT

The endothelin family has been related with several pathological diseases including cardiovascular disorders, hypertension and cancer. However, little is known about endothelin system in early stages of colorectal cancer and there are no studies evaluating differences in proximal and distal colon segments. To deepen in this issue, we have studied the endothelin’s family gene and protein expression in normal mice and early stage of a mice model of Azoxymethane (AOM) and Dextran Sodium Sulphate (DSS) induced colorectal cancer in proximal and distal segments. Additionally, using nonlinear microscopy (NLM) techniques, we have characterized collagen changes in early stages of cancer disease development. In the present study, we have found significant differential gene expression and protein localization between these colon regions, which allow us to hypothesize a new role for the ET-2 as an early marker of colon cancer development.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

M. Bianchi, J. Adur, M. Izaguirre, S. Viale, C. Cesar and V. Casco, "Endothelin-2 Differential Expression in Normal and Early-Stages of Colon Cancer Development," Journal of Cancer Therapy, Vol. 4 No. 6B, 2013, pp. 26-33. doi: 10.4236/jct.2013.46A2004.

References

[1] K. Saida, Y. Mitsui and N. Ishida, “A Novel Peptide, vasoactive Intestinal Contractor, of a New (Endothelin) Peptide Family. Molecular Cloning, Expression, and Biological Activity,” Journal of Biological Chemistry, Vol. 264, No. 25, 1989, pp. 14613-14616.
[2] A. K. Khimji and D. C. Rockey, “Endothelin—Biology and Disease,” Cellular Signalling, Vol. 22, No. 11, 2010, pp. 1615-1625. doi:10.1016/j.cellsig.2010.05.002
[3] I. Chang, A. N. Bramall, A. G. Baynash, A. Rattner, D. Rakheja, M. Post, S. Joza, C. McKerlie, D. J. Stewart, R. R. McInnes and M. Yanagisawa, “Endothelin-2 Deficiency Causes Growth Retardation, Hypothermia, and Emphysema in Mice,” The Journal of Clinical Investigation, 2013. doi:10.1172/JCI66735
[4] M. Bianchi, J. F. Adur, S. Takizawa, K. Saida and V. H. Casco, “Endothelin System in Intestinal Villi: A Possible Role of Endothelin-2/Vasoactive Intestinal Contractor in the Maintenance of Intestinal Architecture,” Biochemical and Biophysical Research Communications, Vol. 417, No. 4, 2012, pp. 1113-1118. doi:10.1016/j.bbrc.2011.12.053
[5] S. Takizawa, T. Uchide, J. Adur, T. Kozakai, E. Kotake-Nara, J. Quan and K. Saida, “Differential Expression of Endothelin-2 along the Mouse Intestinal Tract,” Journal of Molecular Endocrinology, Vol. 35, No. 2, 2005, pp. 201-209. doi:10.1677/jme.1.01787
[6] S. Takizawa, T. Uchide, T. Kozakai, J. Adur, J. Quan and K. Saida, “Immunolocalization of Endothelin-B Receptor in Mouse Intestinal Tract,” Journal of Cardiovascular Pharmacology, Vol. 44, 2004, pp. S329-S331. doi:10.1097/01.fjc.0000166285.85785.7a
[7] H. Ali, M. Dashwood, K. Dawas, M. Loizidou, F. Savage and I. Taylor, “Endothelin Receptor Expression in Colorectal Cancer,” Journal of Cardiovascular Pharmacology, Vol. 36, Suppl. 1, 2000, pp. S69-S71.
[8] G. Egidy, L. Juillerat-Jeanneret, J. F. Jeannin, P. Korth, F. T. Bosman and F. Pinet, “Modulation of Human Colon Tumor-Stromal Interactions by the Endothelin System,” The American Journal of Pathology, Vol. 157, No. 6, 2000, pp. 1863-1874. doi:10.1016/S000
[9] M. M. Hoosein, M. R. Dashwood, K. Dawas, H. M. Ali, K. Grant, F. Savage, I. Taylor and M. Loizidou, “Altered Endothelin Receptor Subtypes in Colorectal Cancer,” European Journal of Gastroenterology & Hepatology, Vol. 19, No. 9, 2007, pp. 775-782. doi:10.1097/MEG.0b013e3282c563de
[10] L. P. Eberl, O. Valdenaire, V. Saintgiorgio, J. F. Jeannin and L. Juillerat-Jeanneret, “Endothelin Receptor Blockade Potentiates FasL-Induced Apoptosis in Rat Colon Carcinoma Cells,” International Journal of Cancer, Vol. 86, No. 2, 2000, pp. 182-187. doi:10.1002/(SICI)1097-0215(20000415)86:2<182::AID-IJC6>3.0.CO;2-G
[11] R. Wang, C. V. L?hr, K. Fischer, W. M. Dashwood, J. A. Greenwood, E. Ho, D. E. Williams, H. Ashktorab, M. R. Dashwood and R. H. Dashwood, “Epigenetic Inactivation of Endothelin-2 and Endothelin-3 in Colon Cancer,” International Journal of Cancer, Vol. 132, No. 5, 2013, pp. 1004-1012.
[12] D. W. Rosenberg, C. Giardina and T. Tanaka, “Mouse Models for the Study of Colon Carcinogenesis,” Carcinogenesis, Vol. 30, No. 2, 2009, pp. 183-196. doi:10.1093/carcin/bgn267
[13] T. Tanaka, “Colorectal Carcinogenesis: Review of Human and Experimental Animal Studies,” Journal of Carcinogenesis, Vol. 8, No. 1, 2009, p. 5. doi:10.4103/1477-3163.49014
[14] M. D. Robertis, E. Massi, M. L. Poeta, S. Carotti, S. Morini, L. Cecchetelli, E. Signori and V. M. Fazio, “The AOM/DSS Murine Model for the Study of Colon Carcinogenesis: From Pathways to Diagnosis and Therapy Studies,” Journal of Carcinogenesis, Vol. 10, No. 1, 2011, p. 9. doi:10.4103/1477-3163.78279
[15] L. Bugnon, “Dise?o y Desarrollo de un Sistema para Fotodocumentación y anáLisis Cuantitativo de Geles de Electroforesis,” Degree Bioengineering Thesis, Facultad de Ingeniería, Universidad Nacional de Entre Ríos, Concepción del Uruguay, 2013.
[16] J. Adur, V. B. Pelegati, A. A. de Thomaz, M. O. Baratti, D. B. Almeida, L. A. Andrade, F. Bottcher-Luiz, H. F. Carvalho, C. L. Cesar, “Optical Biomarkers of Serous and Mucinous Human Ovarian Tumor Assessed with Nonlinear Optics Microscopies,” Plos One, Vol. 7, No. 10, 2012, Article ID: e47007. doi:10.1371/journal.pone.0047007
[17] G. Bkaily, L. Avedanian, J. Al-Khoury, C. Provost, M. Nader, P. D’Orléans-Juste and D. Jacques, “Nuclear Membrane Receptors for ET-1 in Cardiovascular Function,” American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Vol. 300, No. 2, 2011, pp. R251-R263. doi:10.1152/ajpregu.00736.2009
[18] G. Bkaily, L. Avedanian, J. Al-Khoury, L. Ahmarani, C. Perreault and D. Jacques, “Receptors and Ionic Transporters in Nuclear Membranes: New Targets for Therapeutical Pharmacological Interventions,” Canadian Journal of Physiology and Pharmacology, Vol. 90, No. 8, 2012, pp. 953-965. doi:10.1139/y2012-077
[19] J. C. Honore, E. Carrier, M. H. Fecteau, C. R. Tirapelli, G. Bkaily and P. D’Orleans-Juste, “Nonselective ETA/ETBReceptor Blockade Increases Systemic Blood Pressure of Bio 14. 6 Cardiomyopathic Hamsters,” This Article Is One of a Selection of Papers Published in the Special Issue (Part 1 of 2) on Forefronts in Endothelin, Canadian Journal of Physiology and Pharmacology, Vol. 86, No. 6, 2008, pp. 394-401. doi:10.1139/Y08-041
[20] L. Avedanian, D. Jacques and G. Bkaily, “Presence of Tubular and Reticular Structures in the Nucleus of Human Vascular Smooth Muscle Cells,” Journal of Molecular and Cellular Cardiology, Vol. 50, No. 1, 2011, pp. 175-186. doi:10.1016/j.yjmcc.2010.10.005
[21] J. Adur, T. Uchide, S. Takizawa, J. Quan and K. Saida, “Real-Time Polymerase Chain Reaction Quantification of Gene Expression Levels of Murine Endothelin-A and Endothelin-B Receptors: Gene Expression Profiles by the Standard Curve Method,” Journal of Cardiovascular Pharmacology, Vol. 44, Suppl. 1, 2004, pp. S321-S328. doi:10.1097/01.fjc.0000166270.01926.00
[22] J. F. Adur and V. H. Casco, “Endotelinas Murinas,” Editorial Académica Espa?ola, Saarbrücken, 2011.
[23] T. H. Kim, H. Xiong, Z. Zhang and B. Ren, “β-Catenin Activates the Growth Factor Endothelin-1 in Colon Cancer Cells,” Oncogene, Vol. 24, No. 4, 2004, pp. 597-604. doi:10.1038/sj.onc.1208237
[24] E. Asham, A. Shankar, M. Loizidou, S. Fredericks, K. Miller, P. B Boulos, G Burnstock and I. Taylor, “Increased Endothelin-1 in Colorectal Cancer and Reduction of Tumour Growth by ET A Receptor Antagonism,” British Journal of Cancer, Vol. 85, No. 11, 2001, p. 1759. doi:10.1054/bjoc.2001.2193
[25] L. Coffman, C. Mooney, J. Lim, S. Bai, I. Silva, Y. Gong, K. Yang and R. J. Buckanovich, “Endothelin Receptor-A Is Required for the Recruitment of Antitumor T Cells and Modulates Chemotherapy Induction of Cancer Stem Cells,” Cancer Biology & Therapy, Vol. 14, No. 2, 2013, pp. 184-192. doi:10.4161/cbt.22959
[26] A. Bagnato, F. Spinella and L. Rosanò, “Emerging Role of the Endothelin Axis in Ovarian Tumor Progression,” Endocrine-related Cancer, Vol. 12, No. 4, 2005, pp. 761-772. doi:10.1677/erc.1.01077
[27] L. Rosanò, V. Di Castro, F. Spinella, G. Tortora, M. R. Nicotra, P. G. Natali and A. Bagnato, “Combined Targeting of Endothelin A Receptor and Epidermal Growth Factor Receptor in Ovarian Cancer Shows Enhanced Antitumor Activity,” Cancer Research, Vol. 67, No. 13, 2007, pp. 6351-6359. doi:10.1158/0008-5472.CAN-07-0883
[28] L. Rosanò, V. Di Castro, F. Spinella, M. R. Nicotra, P. G. Natali and A. Bagnato, “ZD4054, a Specific Antagonist of the Endothelin A Receptor, Inhibits Tumor Growth and Enhances Paclitaxel Activity in Human Ovarian Carcinoma in Vitro and in Vivo,” Molecular Cancer Therapeutics, Vol. 6, No. 7, 2007, pp. 2003-2011. doi:10.1158/1535-7163.MCT-07-0151
[29] M. A. Carducci and A. Jimeno, “Targeting Bone Metastasis in Prostate Cancer with Endothelin Receptor Antagonists,” Clinical Cancer Research, Vol. 12, No. 20, 2006, pp. 6296s-6300s. doi:10.1158/1078-0432.CCR-06-0929
[30] H. Q. Mai, Z. Y. Zeng, K. T. Feng, Y. L. Ye, C. Q. Zhang, W. J. Liang, X. Guo, H. Y. Mo and M. H. Hong, “Therapeutic Targeting of the Endothelin a Receptor in Human Nasopharyngeal Carcinoma,” Cancer Science, Vol. 97, No. 12, 2006, pp. 1388-1395. doi:10.1111/j.1349-7006.2006.00333.x
[31] L. Boldrini, S. Gisfredi, S. Ursino, P. Faviana, M. Lucchi, F. Melfi, A. Mussi, F. Basolo and G. Fontanini, “Expression of Endothelin-1 Is Related to Poor Prognosis in Non-Small Cell Lung Carcinoma,” European Journal of Cancer, Vol. 41, No. 18, 2005, pp. 2828-2835. doi:10.1016/j.ejca.2005.08.030
[32] M. Felx, M. Guyot, M. Isler, R. Turcotte, J. Doyon, A. M. Khatib, S. Leclerc A. Moreau and F. Moldovan, “Endothelin-1 (ET-1) Promotes MMP-2 and MMP-9 Induction Involving the Transcription Factor NF-kappaB in Human Osteosarcoma,” Clinical Science, Vol. 110, 2006, pp. 645-654. doi:10.1042/CS20050286
[33] C. Chao, J. R. Carmical, K. L. Ives, T. G. Wood, J. F. Aronson, G. A. Gomez, C. D. Djukom and M. R. Hellmich, “CD133+ Colon Cancer Cells Are More Interactive with the Tumor Microenvironment than CD133-Cells,” Laboratory Investigation Vol. 92, No. 3, 2012, pp. 420-436. doi:10.1038/labinvest.2011.185
[34] S. Zhuo, J. Chen, W. G. Wu, S. Xie, L. Zheng, X. Jiang and X. Zhu, “Quantitatively Linking Collagen Alteration and Epithelial Tumor Progression by Second Harmonic Generation Microscopy,” Applied Physics Letters, Vol. 96, No. 21, 2010, pp. 1-3. doi:10.1063/1.3441337
[35] P. P. Provenzano, C. T. Rueden, S. M. Trier, L. Yan, S. M. Ponik, D. R. Inman, P. J. Keely and K. W. Eliceiri, “Nonlinear Optical Imaging and Spectral-Lifetime Computational Analysis of Endogenous and Exogenous Fluorophores in Breast Cancer,” Journal of Biomedical Optics, Vol. 13, No. 3, 2008, Article ID: 031220. doi:10.1117/1.2940365
[36] P. P. Provenzano, K. W. Eliceiri, L. Yan, A. Ada-Nguema, M. W. Conklin, D. R. Inman and P. J. Keely, “Nonlinear Optical Imaging of Cellular Processes in Breast Cancer,” Microscopy and Microanalysis, Vol. 14, No. 6, 2008, pp. 532-548. doi:10.1017/S1431927608080884
[37] P. P. Provenzano, D. R. Inman, K. W. Eliceiri, S. M. Trier and P. J. Keely, “Contact Guidance Mediated Three-Dimensional Cell Migration Is Regulated by Rho/RockDependent Matrix Reorganization,” Biophysical Journal, Vol. 95, No. 11, 2008, pp. 5374-5384. doi:10.1529/biophysj.108.133116
[38] E. Brown, T. McKee, E. diTomaso, A. Pluen, B. Seed, Y. Boucher and R. K. Jain, “Dynamic Imaging of Collagen and Its Modulation in Tumors In Vivo Using Second-Harmonic Generation,” Nature Medicine, Vol. 9, No. 6, 2003, pp. 796-800. doi:10.1038/nm879
[39] J. N. Rogart, J. Nagata, C. S. Loeser, R. D. Roorda, H. Aslanian, M. E. Robert, W. R. Zipfel and M. H. Nathanson, “Multiphoton Imaging Can Be Used for Microscopic Examination of Intact Human Gastrointestinal Mucosa ex Vivo,” Clinical Gastroenterology and Hepatology, Vol. 6, No. 1, 2008, pp. 95-101. doi:10.1016/j.cgh.2007.10.008
[40] J. P. Knowles, X. Shi-Wen, S. U. Haque, A. Bhalla, M. R. Dashwood, S. Yang, I. Taylor, M. C. Winslet, D. J. Abraham and M. Loizidou, “Endothelin-1 Stimulates Colon Cancer Adjacent Fibroblasts,” International Journal of Cancer, Vol. 130, No. 6, 2012, pp. 1264-1272. doi:10.1002/ijc.26090

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.